home > hygiene > forschungslacknercvv2.html.en

Logo Hygiene EN

Michaela Lackner

Michaela LACKNER
Univ.Prof. Mag.Dr.rer.nat., FECMM

Tel.: +43 (0)512 9003-70725
E-Mail: michaela.lackner@i-med.ac.at

Biographical sketch

Microbiology studies at the Leopold-Franzens-University, Innsbruck, Austria – Master and PhD in Mycology/Molecular Biology, Habilitation at the Medical University of Innsbruck for Hygiene and Medical Microbiology – Molecular Diagnostics – Fungal Taxonomy – Emerging Fungal Pathogens – Antifungal Resistance Epidemiology – Molecular Resistance Mechanisms

Current Position

Full Professor 'Experimental Mycology'
Leader of the Mycology Research Group

Education & Career History

2002	Begin of studies at the LFU (Austria)
2005	First Diploma (equal to BSc) passed with distinction
2007	Master of Science (degree: Mag.rer.nat) passed with distinction
2010	PhD in natural sciences (degree: Dr.rer.nat.) University of Innsbruck (LFU, Austria) passed with distinction
2011 - 2014	PostDoc AspBIOmics (ERAnet FWF project number ZFI006560; PI: Lass-Flörl)
2014 - 2016	Head of the molecular diagnostic unit at HMM (MUI)
2016	Assistenzprofessorin (Junior Professor tenure track) signing qualification criteria at the MUI
2016	Habilitation (venia docendi) in Hygiene and Medical Microbiology (MUI)
2017 - present	Leader of the Mycology at the HMM
2019 - 2021	Associate Professor at the HMM (MUI)
2021 - present	University Professor for 'Experimental Mycology' (Full Professor)

Projects

(1)	Pfizer research grant Project Title: Mucormycetes antifungal resistance mechanism: Mucor circinelloides drug efflux pumps characterization
(2)	ESFIG Study group grant
(3)	F2G - research grant: Title: Olorofim
(4)	FWF-grant P32329-B Title: Characterization of intrinsic azole resistance in mucormycetes
(5)	PSP D-155110-026-013 Title: NCT a potential new inhalative drug for cystic fibrosis patients, granted by Austrian cystic fibrosis foundations
(6)	PSP D-155110-026-011 Title: Testung der Relevanz der hydrophoben Zellwandschicht von Aspergillen in Bezug auf die Colistinresistenz (in English: Relevance of the hydrophobic cell wall compounds of Aspergilli on drug absorbance), granted by Forest Pharma
(7)	PSP D-155110-026-012 Title: Molecular resistance mechanisms granted by Astellas
(8)	MUI Start Projekt-ID 2017-01-008, SAP-Auftragsnr: ST20170108 Title: Azole resistance in mucormycetes, understanding underlying molecular mechanisms granted by the Medical University of Innsbruck

Awards

	Paul Ehrlich Gesellschaft Poster Award 2019
	Österreichischer Habilitationspreis der Dr. Maria Schaumayerstiftung 2018 (habilitation award) AAA Poster Award 2018
	DmykG Forschungspreis 2017 (research award)
	ÖGIT award 2016 "Österreichischer Infektionspreis 2016" (research award)
	Grant for student mobility from the University of Innsbruck (LFU) to enable collaboration with J. Guarro's working group in Spain in 2006

Publications

Other activities

Functions in scientific societies

	ECFS fungal pathogens working group co-coordinator (2020 - present)
	ECFS member (2020 - present)
	FECMM member (2018 - present)
	Faculty member of the ECMM (2016 - present)
	Co-treasurer of the Austrian Society for Medical Mycology (ÖGMM) (12/2012 - present)
	ISHAM council member with voting rights (2012 - 2015)
	Founder and president of the Young ISHAM (2009 - 2015)

International expert groups

	FPCRI expert board (2016 - present)
	FPCRI leader of the clinical translational working party on Mucorales (2016 - present)
	Convenor of the ISHAM working group of Nomenclature of Medical Fungi (2012 - present)
	Convenor of the ECMM/ISHAM working group Scedosporium infections (2010 - present)
	EAPCRI expert board (2011 - 2018)

Conference committees:

	Member of the local committee of the 3rd International Workshop on Scedosporium, Bonn, Germany, 2009
	Member of the DMykG scientific committee ISHAM in Berlin, Germany, 2012
	Member of the organisation board Masterclass barcoding, Utrecht, The Netherlands, 2014
	Member of the organisation committee ISHAM, Melbourne, Australia, 2015
	Member of scientific organisation committee ISHAM, Amsterdam, The Netherlands, 2018
	Member of the local organisation committee for DmykG, Innsbruck, Austria, 2018
	Scientific board member of the XVIII Congress of European Mycologists, Warsaw and Bialowieża, Poland, 2019
	Scientific board member AAAM, online meeting, 2022
	Scientific board member DmkyG, Vienna, Austria, 2022
	Local organisation board ECFG, Innsbruck, Austria, 2023

Other non-scientific function at the Medical University of Innsbruck

	Substitute member of the List Life Sciences – ‘Mittelbau’ – Senate (2013 - 2021)
	Substitute member of the Gender Equality Board (AKGL) (2015 - present)
	Substitute member of the Workers Council for scientific staff (2016 - 2020)
	Member of the Helene Wastl Club (2017 - present)
	Member of the User Board (2019 - 2021)
	Gender Equality Board, substitute member of the Habilitation Commission (2019 - present)
	Member of the Senate of Professors (ProfessorInnenkurie) (2021 - present)

Expert on international guideline groups

(1)	Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. Lancet Infect Dis. 2021, Aug;21(8):e246-e257. doi: 10.1016/S1473-3099(20)30784-2.
(2)	Global guideline for the diagnosis and management of rare molds: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium: Lancet Infect Dis. 2019 Dec; 19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3.
(3)	Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. doi: 10.1016/S1473-3099(19)30312-3.
(4)	ESCMID and ECMM joint clinical guidelines for the diagnosis and management ofmucormycosis 2013. doi: 10.1111/1469-0691.12371.
(5)	ESCMID and ECMM joint clinical guidelines for the diagnosis and management ofrare invasive yeast infections. doi: 10.1111/1469-0691.12360.
(6)	ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. doi: 10.1111/1469-0691.12515.
(7)	ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. doi: 10.1111/1469-0691.12465.

Host of international advanced educational programs:

	CBS Medical Mycology Course: participation & successful completion (04/2010)
	Training in molecular typing and diagnostics at the CWZ under the supervision of J. Meis (CWZ-The Netherlands) (06/2010 - 07/2011)
	Host of the CBS Medical Mycology Course (G.S. de Hoog) (08/2012)
	ESCMID observership at the CWZ for improving routine molecular diagnostics under the guidance of J. Meis and F. Hagen (01/2015)
	Visiting scientist University of Otago (Dunedin, NZ) - Brian Monk (11/2018 - 03/2019)
	Participation in international advanced training programs and internships Visiting scientist University of Otago (Dunedin, NZ) - Brian Monk (03/2020 - 08/2020)

Teaching

Hygiene und Medizinische Mikrobiologie